NCT02362984 - DLBS1033 for the Treatment of Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

April 30, 2017

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Placebo

Placebo of DLBS1033 will be given in addition to the standard therapy consisting of: aspirin enteric-coated tablet 1 x 80 mg daily, simvastatin film-coated tablet 1 x 20 mg daily, vitamin B complex 1 x 1 tablet daily, and citicholine injection 250 mg/2 mL twice daily

DRUG

DLBS1033

DLBS1033 enteric-coated tablets will be given in addition to the standard therapy consisting of: aspirin enteric-coated tablet 1 x 80 mg daily, simvastatin film-coated tablet 1 x 20 mg daily, vitamin B complex 1 x 1 tablet daily, and citicholine injection 250 mg/2 mL twice daily

Trial Locations (1)

43113

RSUD R. Syamsudin, SH, Sukabumi